Soo-Jin Kim
Direttore Tecnico/Scientifico/R&S presso INOZYME PHARMA, INC.
Patrimonio netto: 2 M $ in data 30/06/2024
Profilo
Soo-Jin Kim is currently the Chief Technical Operations Officer & Senior VP at Inozyme Pharma, Inc. Previously, he worked as a Principal Scientist at Bristol Myers Squibb Co., a Senior Research & Head-API Development Group at Boehringer Ingelheim Pharmaceuticals, Inc., and a Senior Vice President & Head-Bio Plant at Hanmi Pharmaceutical Co., Ltd.
He completed his undergraduate degree at Cornell University and holds graduate and doctorate degrees from the California Institute of Technology.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ILSHIN SPINNING CO., LTD
1.31% | 26/04/2023 | 305 460 ( 1.31% ) | 2 M $ | 30/06/2024 |
Posizioni attive di Soo-Jin Kim
| Società | Posizione | Inizio |
|---|---|---|
| INOZYME PHARMA, INC. | Direttore Tecnico/Scientifico/R&S | 08/03/2022 |
Precedenti posizioni note di Soo-Jin Kim
| Società | Posizione | Fine |
|---|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - |
| HANMI PHARM. CO., LTD. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Formazione di Soo-Jin Kim
| Cornell University | Undergraduate Degree |
| California Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| HANMI PHARM. CO., LTD. | Health Technology |
| INOZYME PHARMA, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
- Borsa valori
- Insiders
- Soo-Jin Kim
